NCT06982066 · Connecticut Children's Medical Center
Improving Communication Between AYA Oncology Patients and Clinicians: A Patient-Centered Intervention
What this study is about
The overarching goal is to develop and demonstrate proof-of-concept of ReSPECT (Reproductive and Sexual Health Patient Education and Communication Tool), a multi-modal communication intervention to improve adolescent and young adult (AYA)- clinician sexual and reproductive health (SRH) communication in the outpatient oncology clinic setting.
View original scientific description
The overarching goal is to develop and demonstrate proof-of-concept of ReSPECT (Reproductive and Sexual Health Patient Education and Communication Tool), a multi-modal communication intervention to improve adolescent and young adult (AYA)- clinician sexual and reproductive health (SRH) communication in the outpatient oncology clinic setting.
Who can participate
This study lists these criteria on ClinicalTrials.gov. A study coordinator reviews eligibility during screening — this page does not determine whether you qualify.
Inclusion criteria
- Adolescent and Young Adult Oncology Patients In order to be eligible to participate in this study, an individual must meet all of the following criteria:
- Be aged 15-25 years old at time of enrollment.
- Have a cancer diagnosis and currently be on cancer-directed therapy with at least one of the following:
- Chemotherapy: any anticancer drug to treat the cancer diagnosis, including immunotherapy.
- Radiotherapy: any radiotherapy to treat the cancer diagnosis.
- Surgery: any surgery to remove cancer including partial of total resections. Biopsies are not considered surgery.
- Be greater than or equal to 2 months from diagnosis/initiation of therapy, whichever occurred later.
- Be able to speak and read English
- Have permission to participate from a member of the patient's primary oncology team.
- Provision to sign and date the consent/assent form.
- Active study participation of primary oncology clinician
- Patient must have primary oncology care at Connecticut Children's Center for Cancer \& Blood Disorders of Children's Hospital Los Angeles Cancer \& Blood Disease Institute
Exclusion criteria
- An individual who meets and of the following criteria will be excluded from participation in this study:
- Not currently on cancer-directed therapy.
- Unable to speak and read English.
- Insufficient cognitive functioning to complete study measures (as determined by a member of the patient's primary oncology team) Pediatric Oncology Clinicians 1\. Be a pediatric oncology physician, clinical fellow, or advanced practice provider (including nurse practitioners and physician assistants) that provides clinical care for AYA patients with cancer
Where
- Hartford, Connecticut
Frequently asked questions
What is a clinical trial?
A clinical trial is a research study that tests new medical treatments, drugs, devices, or procedures to determine their safety and effectiveness. Trials are carefully designed and monitored to protect participants while advancing medical knowledge.
Is it safe to participate?
Clinical trials follow strict safety guidelines and ethical standards. Trials must be reviewed and approved, and participants are closely monitored by medical professionals throughout the study. You can withdraw at any time if you choose.
Will I be compensated?
Many clinical trials offer compensation for your time, travel expenses, and inconvenience. The specific compensation varies by study and will be discussed during the screening process. All study-related medical care is typically provided at no cost to participants.
Will I receive a placebo instead of treatment?
When effective treatment exists, participants typically receive either the standard treatment plus the study intervention, or the standard treatment plus placebo. You would not be denied effective care. Placebos are primarily used when no proven treatment is available, or in addition to standard care. Your trial consent form will clearly explain what treatments you may receive.
Can I leave a trial if I change my mind?
Absolutely. Participation in clinical trials is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty or loss of benefits to which you are otherwise entitled.
How long does a clinical trial last?
Trial duration varies widely depending on the study design and purpose. Some trials last just a few weeks, while others may continue for months or years. The study coordinator will provide specific timeline information during your screening call.
Data: ClinicalTrials.gov · synced Aug 14, 2025 · Source of record for eligibility and locations